The pulmonary effects of intravenous adenosine in asthmatic subjects. - Wikidata - awgldk - TriplyDB

The pulmonary effects of intravenous adenosine in asthmatic subjects.

The pulmonary effects of intravenous adenosine in asthmatic subjects.

http://www.wikidata.org/entity/Q35214414

about

Ticagrelor: Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Profile: An Update Blockade of airway sensory nerves and dyspnea in humans Mechanisms of dyspnea Predictors and Diagnostic Significance of the Adenosine Related Side Effects on Myocardial Perfusion SPECT/CT Imaging.Vagal Afferent Innervation of the Airways in Health and Disease.Potential role of endogenous adenosine in ticagrelor-induced dyspnea.Pharmacological treatment of refractory breathlessness.Post-reperfusion bronchospasm in a deceased donor liver transplant recipient: An enigma.Management of Supraventricular Tachycardia in Infants.

P2860

Q27006031-52AB1BEA-A1EA-40E8-A936-6E29542D16E9 Q33912946-7F7C111B-394A-4FA5-8CC7-3D07428DC23F Q34275333-C6AA0B64-0760-4BDD-B308-D6936F3E9E9E Q34883899-16A13FAC-40C2-4682-AD35-67C81F4023B2 Q37169500-71468AF7-4089-4EB9-AC3E-198FA723C5DC Q38109844-9BF3D87C-ED76-44FA-A1EB-469FC0AFCFE5 Q43061646-C90AB66B-5CBD-42A1-A652-95DE9671B88C Q47133245-43C9F7BE-B3D8-4CE3-8689-9E3874BEBAA5 Q50238151-D9AB9951-C0C7-489F-BC33-5FAED055B0E9

P2860

The pulmonary effects of intravenous adenosine in asthmatic subjects.

http://www.wikidata.org/entity/Q35214414

description

2006 nî lūn-bûn

@nan

2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

The pulmonary effects of intravenous adenosine in asthmatic subjects.

@ast

The pulmonary effects of intravenous adenosine in asthmatic subjects.

@en

type

label

The pulmonary effects of intravenous adenosine in asthmatic subjects.

@ast

The pulmonary effects of intravenous adenosine in asthmatic subjects.

@en

prefLabel

The pulmonary effects of intravenous adenosine in asthmatic subjects.

@ast

The pulmonary effects of intravenous adenosine in asthmatic subjects.

@en

P1433

Q35214414-EFF33E36-01FF-48B5-812B-36C5A7191B97

P1476

Q35214414-31869AF9-3D12-42C6-88A7-24457D4169A6

P2093

Q35214414-146DDB6A-8219-4D7B-8BF9-6BF54907158A

Q35214414-2C41BDA5-3E93-4323-A28B-4DC9CFE2B331

P2860

Q35214414-14D4F299-DCEE-4AE0-BB82-616784799CA7

Q35214414-175B85C6-6513-4DC4-B1A6-FCE90262DA45

Q35214414-1E76248B-5DAC-41D9-A975-30E3A8EC1104

Q35214414-3CD4D539-DABD-4455-B2E8-8CD8DC7CBCD4

Q35214414-45C87246-930F-4C43-B023-0C65F31C1D54

Q35214414-4ADE25FE-36A6-45FF-8F86-05E601F31A69

Q35214414-50680151-1C7F-43F9-8FD9-629F6FDF2C73

Q35214414-5A3991B1-5DBF-4B26-86C3-FA50814FA531

Q35214414-5B59E00D-38DF-496E-BA12-7ED9677FEDE9

Q35214414-659C9B7D-6B00-4416-A6C1-B96A86331F62

P2888

Q35214414-4135EC12-889C-4881-976A-5C4080B6933C

P304

Q35214414-3972CB49-7B4D-4F74-9DD6-2A8381263F66

P31

Q35214414-3F5C8678-D606-4EEA-B354-B912A39FF0AF

P356

Q35214414-5D98CDC6-DBB5-49D9-9F33-54469FF9BE67

P478

Q35214414-41354EAF-3996-4774-83E9-FC0DEEFCDE3E

P50

Q35214414-633FCC47-BDFB-4B8C-8AC8-265D9B053767

P577

Q35214414-3D0C5E41-B05C-41C3-88F9-3222DC80E6B2

P5875

Q35214414-6953F7A3-72DC-4294-BEC1-0C70D1288531

P6179

Q35214414-A084FF35-52B2-433B-A321-700FF2B43079

P698

Q35214414-F74C20E8-3057-47D9-8C75-D6BF9334C0CD

P921

Q35214414-DDAB2483-9558-4311-A048-66CEA48030BE

P932

Q35214414-E75FBBAF-A62D-4FA6-A7C0-63A352D761BB

P356

1465-9921-7-139

P1433

Respiratory Research

P1476

The pulmonary effects of intravenous adenosine in asthmatic subjects

@en

P2093

Mahmud Alam

http://www.w3.org/2001/XMLSchema#string

Nausherwan K Burki

http://www.w3.org/2001/XMLSchema#string

P2860

Psychophysical bases of perceived exertion

Adenosine monophosphate and histamine induced bronchoconstriction: repeatability and protection by terbutaline

Adenosine and the treatment of supraventricular tachycardia.

Respiratory sensation during bronchial challenge testing with methacholine, sodium metabisulphite, and adenosine monophosphate

Dyspnea. Pathophysiologic basis, clinical presentation, and management.

Effect of vagotomy on the breathing pattern and exercise ability in emphysematous patients.

Thoracic receptors connected with sensation.

Mechanism of airway inflammation in asthma.

Breathlessness and mouth occlusion pressure in patients with chronic obstruction of the airways.

Effect of low dose nebulised morphine on exercise endurance in patients with chronic lung disease.

P2888

1465-9921-7-139

P304

139

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1465-9921-7-139

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-11-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6660429

http://www.w3.org/2001/XMLSchema#string

P6179

1014306216

http://www.w3.org/2001/XMLSchema#string

P698

17137511

http://www.w3.org/2001/XMLSchema#string

P921

P932

1693563

http://www.w3.org/2001/XMLSchema#string